Kidney Trouble Doubles Rash Risk During Pancreatic Cancer Drug Combo, Study Finds
A retrospective study of 313 patients found that baseline renal impairment doubled the risk of rash during gemcitabine plus nab-paclitaxel ...
A retrospective study of 313 patients found that baseline renal impairment doubled the risk of rash during gemcitabine plus nab-paclitaxel ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine